Investors & Media


Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets. Additionally, the Company has legacy programs in allergy and viral infections, and inner ear disorders, which it intends to partner as it plans to focus exclusively on the exciting opportunities in RNA.

Investor Contact

Primary IR Contacts
U.S Tel: 800-460-0183